MedTrace Logo

Effect of HFCWO Vests on Spirometry Measurements

NCT03628456 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2019-11-22

Study results available
· View outcomes & findings →

Summary

The impact of high-frequency chest wall oscillation therapy on spirometry values (Forced Expiratory Volume, Forced Vital Capacity, Peak Expiratory Flow, Forced Expiratory Flow and Tidal Volume is investigated during use of several products and comparing to baseline values

Conditions

Interventions

DEVICE

International Biophysics AffloVest

High-frequency chest wall oscillation vest

DEVICE

Hill-Rom Monarch

High-frequency chest wall oscillation vest

Sponsors & Collaborators

  • International Biophysics Corporation

    lead INDUSTRY

Principal Investigators

  • Thomas W O'Brien, MD · PDS Research

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-13
Primary Completion
2018-09-21
Completion
2019-07-02
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03628456 on ClinicalTrials.gov